News

Show
news from

Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer

Freeline Reports Second Quarter 2023 Financial Results and Business Highlights

Purespring Therapeutics appoints Sachin Kelkar as CFO following appointment of Julian Hanak as CEO

Freeline Announces First Patient Dosed with its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

Freeline to Present at 2023 Jefferies Healthcare Conference

Load more

Search